Cargando…
Dispersive Solid Phase Extraction Using Magnetic Nanoparticles Performed in a Narrow-Bored Tube for Extraction of Atorvastatin, Losartan, and Valsartan in Plasma
Purpose: In this investigation, a new version of magnetic solid phase extraction (MSPE) performed in a narrow–bore tube has been proposed. In this study, hydrophobic octyl (C(8)) functionalized Fe(3)O(4) magnetic nanoparticles (MNPs) stabilized by SiOH groups (Fe(3)O(4)@SiO(2)@C(8)) are used as magn...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468226/ https://www.ncbi.nlm.nih.gov/pubmed/31011568 http://dx.doi.org/10.15171/apb.2019.017 |
Sumario: | Purpose: In this investigation, a new version of magnetic solid phase extraction (MSPE) performed in a narrow–bore tube has been proposed. In this study, hydrophobic octyl (C(8)) functionalized Fe(3)O(4) magnetic nanoparticles (MNPs) stabilized by SiOH groups (Fe(3)O(4)@SiO(2)@C(8)) are used as magnetic nano–sorbents for the extraction of cardiovascular drugs from human plasma prior to their determination by high performance liquid chromatography–photodiode array detection. Methods: After precipitation of the plasma proteins, the supernatant is diluted with deionized water and filled into the narrow–bore tube. Then mg–level of the sorbent is added into the tube. The sorbent is dispersed and moved down through the solution instead of passing the solution from the cartridge. Using an external magnet, the collected nano–sorbents at the bottom of the tube are transferred on top of the solution and released to move down through the solution for three times to increase the extraction efficiency. Results: The linearity of the assay was ranging from 0.4–500 mg mL(-1). The limits of detection and quantification of the method were obtained in the ranges of 0.05–0.07 and 0.16–0.24 mg L(-1), respectively. The extraction recoveries were obtained in the range of 31–49%. Intra– and inter–day precisions were calculated and obtained in the ranges of 5–8 and 7%–9% for 0.5 mg L(-1) of each analyte, and 5–6 and 6%–8% for 2 mg L(-1) of each analyte, respectively. Conclusion: The proposed method was successfully used in determination of the studied drugs in patient’s plasmas. |
---|